These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10052204)

  • 21. [Europe: are you ready? The Euro--the new currency--is arriving. It is a visible sign that the Euro-integration is proceeding with giant steps. In this contribution we want to give you a general review of the changes, political mechanisms and health policies].
    Verworner H
    Osterr Krankenpflegez; 1999 Mar; 52(3):16-8. PubMed ID: 10446591
    [No Abstract]   [Full Text] [Related]  

  • 22. A review of new drugs and indications in 2002: financial speculation or better patent care?
    Prescrire Int; 2003 Apr; 12(64):74-7. PubMed ID: 12674131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transparency of EU medicines agencies.
    Kopp C
    Prescrire Int; 2003 Aug; 12(66):156. PubMed ID: 12908499
    [No Abstract]   [Full Text] [Related]  

  • 24. ['European primary care': a visionary report of the Dutch Health Council on primary health care in the European Union].
    Thomas S
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1086-8. PubMed ID: 15932132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicines to remain with European Commission health directorate.
    Watson R
    BMJ; 2014 Oct; 349():g6514. PubMed ID: 25355097
    [No Abstract]   [Full Text] [Related]  

  • 26. E-health development policies in new member states in Central Europe.
    Duplaga M
    World Hosp Health Serv; 2007; 43(2):34-8. PubMed ID: 17894192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The program of action of the European Union in the area of Public Health].
    Calvete A
    Rev Esp Salud Publica; 2003; 77(5):517-21. PubMed ID: 14608955
    [No Abstract]   [Full Text] [Related]  

  • 28. [War on Drugs or War against Health? The pitfalls for public health of Puerto Rican drug policy].
    Santiago-Negrón S; Albizu-García CE
    P R Health Sci J; 2003 Mar; 22(1):49-59. PubMed ID: 12733445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs, devices, diagnostics, and policies: the year's review.
    Kupecz D
    Nurse Pract; 2000 Feb; 25(2):42, 45-8, 51-3; quiz 54-5. PubMed ID: 10703024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescrire's proposals to France's national conference on medicines policy: patients' interests and public health should come first.
    Prescrire Int; 2011 May; 20(116):136-8. PubMed ID: 21648182
    [No Abstract]   [Full Text] [Related]  

  • 31. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical regulation in the European Community: barriers to single market integration.
    Orzack LH; Kaitin KI; Lasagna L
    J Health Polit Policy Law; 1992; 17(4):847-68. PubMed ID: 1299692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Medical Product Agency's work and economics--a comment].
    Ahlqvist Rastad J; Salmonson T
    Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382
    [No Abstract]   [Full Text] [Related]  

  • 34. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ
    Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Import and export of drugs for own use].
    Bjerke M
    Tidsskr Nor Laegeforen; 2010 Jun; 130(12):1260-1. PubMed ID: 20567281
    [No Abstract]   [Full Text] [Related]  

  • 36. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race-specific drugs: regulatory trends and public policy.
    Winickoff DE; Obasogie OK
    Trends Pharmacol Sci; 2008 Jun; 29(6):277-9. PubMed ID: 18453000
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Children on the drug development map. The Danish Society of Clinical Pharmacology].
    Thirstrup S; Heisterberg J;
    Ugeskr Laeger; 2008 Mar; 170(12):1039. PubMed ID: 18397657
    [No Abstract]   [Full Text] [Related]  

  • 40. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.